Nexcore announces acquisition of Meditron product line from CooperSurgical

Nexcore Technologies, Inc. of Waldwick, an original equipment manufacturer of medical devices, today announced it has acquired the Meditron line of gastroenterology endoscopy products from CooperSurgical, Inc. of Trumbull, CT.

Milton Frank, President & CEO of Nexcore Technologies, said the acquisition is an important component of his company's growth in gastroenterology endoscopy products, noting that the Meditron product line is known throughout the medical community for quality, reliability and competitive pricing.

"A key component of this acquisition is our company's dedication to customer service," said Frank, noting the product line of pumps, probes and electro-surgical generators are all manufactured at the company's 30,000-square-foot facility in Waldwick. "We recognize the critical importance of these products to physicians, surgical centers and hospitals. That is why we have set up our internal systems to ship the same day as orders are made."

"This divestiture of a non-strategic asset will serve to consolidate our position in women's health while allowing Nexcore to use their resources in gastroenterology to expand this important technology," said Robert Auerbach, MD, Senior Vice President & Chief Medical Officer of CooperSurgical.

Source:

Nexcore Technologies, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Update on diagnosis, risk classification and treatment of Kawasaki Disease